Pioglitazone 15 mg is a medication used to treat type 2 diabetes. It belongs to a class of drugs known as thiazolidinediones, which work by helping the body use insulin more effectively. Pioglitazone 15 mg is also known as Actos and is available in tablet form. It is usually prescribed to be taken once a day, although the exact dosage and duration of treatment will depend on the individual. Taking pioglitazone 15 mg can help to improve blood sugar control and reduce the risk of long-term complications associated with diabetes, such as heart disease, stroke, and kidney damage.
Pioglitazone 15 mg works by increasing the body’s sensitivity to insulin. Insulin is a hormone produced by the pancreas that helps the body to use glucose (sugar) from food for energy. In people with type 2 diabetes, the body's cells become resistant to the effects of insulin, meaning that the pancreas has to produce more insulin to keep blood sugar levels stable. By increasing the body’s sensitivity to insulin, pioglitazone 15 mg helps the pancreas to produce less insulin, which can help to improve blood sugar control.
Taking pioglitazone 15 mg can help to improve blood sugar control and reduce the risk of long-term complications associated with diabetes. Specifically, pioglitazone 15 mg can help to: • Lower blood sugar levels • Reduce the risk of heart disease • Reduce the risk of stroke • Reduce the risk of kidney damage • Reduce the risk of nerve damage • Reduce the risk of eye damage • Reduce the risk of amputation • Reduce the risk of death from diabetes-related complications
Pioglitazone 15 mg is usually prescribed to people with type 2 diabetes who have not been able to control their blood sugar levels with diet and exercise alone. It is also sometimes prescribed to people with type 2 diabetes who are taking other medications to help control their blood sugar levels.
Like all medications, pioglitazone 15 mg can cause side effects. The most common side effects include: • Weight gain • Swelling in the hands and feet • Headache • Diarrhea • Nausea • Muscle pain • Weakness More serious side effects, such as an increased risk of heart failure, have been reported in some people taking pioglitazone 15 mg. If you experience any of these side effects, you should talk to your doctor as soon as possible.
Pioglitazone 15 mg is a medication used to treat type 2 diabetes. It works by increasing the body’s sensitivity to insulin, which can help to improve blood sugar control and reduce the risk of long-term complications associated with diabetes. Taking pioglitazone 15 mg can also help to reduce the risk of heart disease, stroke, kidney damage, nerve damage, eye damage, amputation, and death from diabetes-related complications. Pioglitazone 15 mg is usually prescribed to people with type 2 diabetes who have not been able to control their blood sugar levels with diet and exercise alone. Although it can be effective, it can also cause side effects, such as weight gain, swelling in the hands and feet, headache, diarrhea, nausea, muscle pain, and weakness. If you experience any of these side effects, you should talk to your doctor as soon as possible.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation